Published Date : 19/07/2025
Artificial intelligence (AI) is reshaping the field of medical diagnostics. With AI algorithms becoming capable of analyzing large amounts of medical data, including imaging scans such as X-rays, CT scans, and MRIs, early and precise disease detection is becoming increasingly achievable.
As artificial intelligence (AI) continues to evolve, its role in healthcare diagnostics is becoming increasingly prominent, often in subtle yet impactful ways. In India, where medical infrastructure and patient volumes can present unique challenges, AI-driven tools are beginning to speed clinical workflows across specialties. From radiology software to ElectroCardioGram (ECG) interpretation, these technologies are designed not to replace physicians, but to assist them by flagging abnormalities, enhancing pattern recognition, and leading to closer inspection of subtle clinical signs.
Traditionally, identifying certain conditions, particularly in their early stages, has posed a significant challenge, even for the most skilled clinicians. Dr. Shivam Singh, a Resident Doctor at Apollo Hospital in Delhi, shares his experience: “In my day-to-day practice, I have started seeing AI show up quietly, often embedded in radiology software, ECG readers, or even in a quick search online. It is not taking over, but it is offering quick insights, pattern recognition, or risk flags that help guide thinking. For example, AI might highlight a subtle prolongation in PR interval or inversion in certain wave forms on ECG or highlight some arrhythmia, but still needs evaluation as what it mostly terms abnormal could be physiological or normal for the given patient based on their presentation. It is good enough to take a look once which could be missed in an otherwise normal looking ECG, thus not to override my judgment, but to sharpen it. It is like an assistant, not the pilot.”
One of the most significant impacts of AI has been in the field of oncology. Researchers at Harvard Medical School in the United States recently unveiled a foundation model, codenamed “Chief,” which demonstrated accuracy in detecting a broad range of cancers. In clinical tests, it improved diagnostic performance by up to 36% compared to earlier AI models, achieving up to 94% accuracy in some cancer types. Such precision allows for earlier detection of malignant tumors, offering patients a better prognosis and more treatment options.
Researchers at UCLA also in the United States developed an AI tool that identifies prostate cancer with an accuracy of 84%, significantly higher than the 67% rate achieved by traditional clinical methods. Not only does this improve the detection rate, but it also reduces the likelihood of residual tumor cells remaining after surgery. Breast cancer diagnosis has also benefited greatly from AI integration. A large-scale Swedish study published in 2023 found that mammograms assessed with the assistance of AI identified 20% more cancers than those examined by radiologists alone. Google DeepMind’s AI system, tested in the United Kingdom and the United States, was shown to reduce both false positives and false negatives in mammography readings.
Beyond cancer, AI is proving highly effective in diagnosing osteoporosis through routine dental and bone X-rays. A 2020 meta-analysis found that AI systems demonstrated 96% sensitivity and 95% specificity in detecting low bone density and other early indicators of osteoporosis. More recently, dental AI models were shown to accurately assess bone health from panoramic X-rays with a similarly high level of precision, helping clinicians identify patients at risk of fractures well before symptoms appear.
AI’s usage extends far beyond oncology and orthopedics. In respiratory medicine, AI algorithms analyzing chest X-rays have achieved near-perfect sensitivity in flagging scans with no significant abnormalities, enabling radiologists to focus on cases that require closer attention. Similarly, in gastroenterology, AI is being used to identify early signs of stomach cancer and to predict flare-ups in chronic conditions like ulcerative colitis.
In diabetic care, AI has shown promise in identifying diabetic retinopathy, a leading cause of blindness in adults. The first autonomous AI diagnostic system for this condition was approved by the US Food and Drug Administration in 2020, marking a major milestone in real-world clinical deployment. By analyzing retinal images with high accuracy, this system allows for early intervention before irreversible damage occurs, especially in regions where ophthalmologists are scarce.
What makes AI particularly effective in diagnostics is its ability to process and learn from millions of data points, recognizing complex patterns invisible to the human eye. Convolutional neural networks can be trained to differentiate between benign and malignant tumors based on subtle image features that even experienced clinicians may miss. Sheikh, Chief AI/ML Engineer at Redacto Singapore, explains: “Over the past decade, AI in diagnostics has transitioned from basic pattern recognition to advanced deep learning models capable of analyzing complex medical images and unstructured data. The integration of big data, cloud computing, and improved algorithms has enabled real-time, scalable diagnostic support, improving both speed and accuracy.”
Despite these advances, AI in diagnosis is not without its challenges. The accuracy of any AI model is heavily dependent on the quality and diversity of the data it is trained on. Biases in training data, such as underrepresentation of certain ethnic groups or rare diseases, can lead to inaccuracies in real-world use. Additionally, AI systems must be validated across multiple populations and clinical settings before they can be deployed widely. Human supervision remains important, not only to validate AI findings but also to interpret them in the broader context of patient history.
One big issue is over-trust. Just because a tool is AI-powered does not mean it is infallible. Many models lack transparency, they give an output, but do not explain how they got there. That is dangerous in a field like medicine where accountability and reasoning matter. Another issue is bias, if AI is trained on data that underrepresents certain populations, it may underperform or misdiagnose. Also, most AI tools are not designed for resource-constrained settings like many parts of India, which limits their generalizability. We need to remember: AI is a tool, not a replacement for critical thinking. But with the upcoming xAI, the how can be more transparent, yet will need the human knowledge and experience to judge its accuracy and relevance,” adds Dr. Singh.
Privacy and data security are also significant concerns. Medical AI systems must comply with strict regulatory frameworks to ensure that patient information is handled responsibly. Moreover, integrating AI tools into existing clinical workflows requires careful planning, technical infrastructure, and training for healthcare professionals. “Data privacy is non-negotiable. Any AI tool we consider must be vetted for encryption, anonymization, and compliance with national guidelines like NDHM or international standards like HIPAA. But beyond the tech safeguards, there is also clinical responsibility. As a physician, I make sure no identifiable patient data is shared on open platforms, and I avoid AI tools that do not have a clear privacy policy or institutional backing,” says Dr. Singh.
Q: How is AI improving cancer diagnosis?
A: AI is improving cancer diagnosis by analyzing large amounts of medical data and detecting subtle patterns that human clinicians might miss. This leads to earlier and more accurate detection of cancers, improving patient outcomes.
Q: What are the challenges of using AI in medical diagnostics?
A: Challenges include biases in training data, over-reliance on AI, and the need for human supervision. AI systems must also be validated across diverse populations and comply with strict data privacy regulations.
Q: How is AI being used in osteoporosis diagnosis?
A: AI systems can analyze routine dental and bone X-rays with high accuracy, detecting early indicators of osteoporosis and helping identify patients at risk of fractures before symptoms appear.
Q: What role does AI play in diabetic retinopathy diagnosis?
A: AI is used to analyze retinal images and identify diabetic retinopathy, a leading cause of blindness in adults. This allows for early intervention and treatment, especially in regions where ophthalmologists are scarce.
Q: How are healthcare professionals adapting to the use of AI in diagnostics?
A: Healthcare professionals are integrating AI as a tool to assist them, not replace them. They use AI to flag abnormalities and enhance pattern recognition, but ultimately rely on their own judgment and expertise to interpret AI findings and make clinical decisions.